Clinical Significance of Serum Levels of Soluble Triggering Receptor Expressed on Myeloid Cells-1 and Soluble Urokinase Type Plasminogen Activator Receptor in Children with Primary Nephrotic Syndrome
返回论文页
|更新时间:2022-11-03
|
Clinical Significance of Serum Levels of Soluble Triggering Receptor Expressed on Myeloid Cells-1 and Soluble Urokinase Type Plasminogen Activator Receptor in Children with Primary Nephrotic Syndrome
Wang Shujing, Tong Xiao, Chen Zhemin. Clinical Significance of Serum Levels of Soluble Triggering Receptor Expressed on Myeloid Cells-1 and Soluble Urokinase Type Plasminogen Activator Receptor in Children with Primary Nephrotic Syndrome. [J]. 26(12):4-7(2020)
DOI:
Wang Shujing, Tong Xiao, Chen Zhemin. Clinical Significance of Serum Levels of Soluble Triggering Receptor Expressed on Myeloid Cells-1 and Soluble Urokinase Type Plasminogen Activator Receptor in Children with Primary Nephrotic Syndrome. [J]. 26(12):4-7(2020) DOI: 10.13407/j.cnki.jpp.1672.108X.2020.12.002.
Clinical Significance of Serum Levels of Soluble Triggering Receptor Expressed on Myeloid Cells-1 and Soluble Urokinase Type Plasminogen Activator Receptor in Children with Primary Nephrotic Syndrome
Objective: To investigate the correlation between serum levels of soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) and soluble urokinase type plasminogen activator receptor (suPAR) in children with primary nephrotic syndrome (PNS) and pathological types and renal damage. Methods: A total of 124 children with PNS admitted into Affiliated Hospital of Jiangnan University were extracted as the observation group
while 30 healthy children were selected as the control group. According to pathological types
patients in the observation group were divided into the focal segmental glomerulosclerosis group (FSGS group
n=35)
the mesangial proliferative glomerulonephritis group (MsPGN group
n=41)
the membranous nephropathy group (MN group
n=27) and the glomerular microlesion group (MCD group
n=21). According to the presence or absence of acute renal injury
patients in the observation group were divided into the renal injury group (n=33) and the non-renal injury group (n=91). The serum levels of sTREM-1 and suPAR were measured
and the correlation with pathological types of PNS and renal injury was analyzed. Results: Levels of sTREM-1
suPAR
total cholesterol (TC)
triglyceride (TG)
serum creatinine (Scr)
uric acid (UA)
24-hour urinary protein (24hUP)
urinary n-acetyl-β-glucosaminidase (uNAG)
urinary microglobulin (uβ2-MG) in the observation group were higher than those in the control group (P<0.05)
and serum protein (ALB) were lower than those in the control group (P<0.05). Serum levels of sTREM-1 and suPAR in the renal injury group were higher than those in the non-renal injury group (P<0.05); there was no statistically significant difference in serum levels of sTREM-1
suPAR among MsPGN group
MN group and MCD group (P>0.05)
which were lower than those of the FSGS group (P<0.05). Serum levels of sTREM-1 and suPAR were positively correlated with TC
TG
24hUP
uNAG and uβ2-MG (P<0.05)
and negatively correlated with ALB (P<0.05). Conclusion: The serum levels of sTREM-1
suPAR in children with PNS increased significantly
which could reflect the pathological types of PNS and renal function to a certain extent.
关键词
原发性肾病综合征可溶性髓样细胞触发受体-1可溶性尿激酶型纤溶酶原激活物受体急性肾损伤
Keywords
primary nephrotic syndromesoluble triggering receptor expressed on myeloid cells-1soluble urokinase type plasminogen activator receptoracute renal injury